Sulfametomidine
Chemical compound
- J01ED03 (WHO)
- 4-amino-N-(6-methoxy-2-methylpyrimidin-4-yl)
benzenesulfonamide
- 3772-76-7 N
- 19596
- 18460 Y
- 940ZL3AHKB
- ChEMBL485940 Y
- DTXSID0023616
- Interactive image
- O=S(=O)(Nc1nc(nc(OC)c1)C)c2ccc(N)cc2
InChI
- InChI=1S/C12H14N4O3S/c1-8-14-11(7-12(15-8)19-2)16-20(17,18)10-5-3-9(13)4-6-10/h3-7H,13H2,1-2H3,(H,14,15,16) Y
- Key:QKLSCPPJEVXONT-UHFFFAOYSA-N Y
Sulfametomidine (or sulfamethomidine) is a sulfonamide antibacterial.[1]
References
- ^ "Sulfametomidine". Inxight Drugs. National Center for Advancing Translational Sciences.
- v
- t
- e
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)
DHFR inhibitor | |||||||||
---|---|---|---|---|---|---|---|---|---|
Sulfonamides (DHPS inhibitor) |
| ||||||||
Combinations |
| ||||||||
Other DHPS inhibitors |
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)
1st generation | |||||||||
---|---|---|---|---|---|---|---|---|---|
Fluoroquinolones |
| ||||||||
Newer non-fluorinated | |||||||||
Related (DG) |
inhibitors
Nitroimidazole derivatives |
---|
Rifamycins/ RNA polymerase | |
---|---|
Lipiarmycins |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e